The Nanomedicine Market is projected to grow at a rate of 12.6% to reach USD 387.11 billion in 2027 from USD 149.53 billion in 2019, according to a new report by Reports and Data. Increased global incidence of cancer coupled with growing prevalence of cardiovascular diseases is likely to be the key factors governing market growth. Based on the WHO statistics, in 2018 around 18.07million new cases were registered for cancer in 2018. Additionally, cancer accounted for around 9.5 million deaths in 2018. The incidence of cancer was significantly high and lied around 48.4 percent in Asia Pacific.

Nanomedicine is being increasingly adopted for the treatment of various diseases including cancer and cardiovascular disease. Apart from improved efficacy and safety, factors such as bio-availability and ability to deliver diagnostic and therapeutic agents to targeted sites are expected to stimulate market growth.

Asia Pacific is expected to be a key revenue generating region in the forecast period. The market is projected to grow at a CAGR of 13.8% in the forecast period. This can be mainly associated with increasing incidence of cancer in the region. Based on estimates, along with high incidence of cancer as compared to other regions, the mortality rate of cancer in Asia is also significantly high. In 2018, the mortality rate was around 57.3 percent for Asia Pacific while it was around 20.3 percent for Europe. Increasing number of deaths of cancer patients is likely to lead to a rise in the adoption of nanomedicine in the region. Moreover, success of nanomedicines in the treatment of heart diseases is also expected to be a major factor affecting demand in the region.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1048

The companies operating in the market and profiled in the report include

Arrowhead Pharmaceuticals Inc. AMAG Pharmaceuticals, Bio-Gate AG, Celgene Corporation and Johnson & Johnson. Johnson & Johnson

The report further discusses in detail the market segmentation

Further key findings from the report suggest

Dendrimers are expected to grow at a significant CAGR in the forecast period. These nano-devices have emerged as a powerful class of nanomaterials owing to their unique features. These nanoparticles are being opted as an efficient therapeutic strategy in the treatment of various neurological disorders.

Asia Pacific market is forecasted to grow significantly in the coming years. Nanomedicines are projected to be opted for the treatment of cancer and cardiovascular disease in the region. Furthermore, efforts by government as well as medical institutes of the region are also anticipated to foster market demand. For instance: Recently in 2018, the Indian Council of Medical Research announced launching nano-medicine task force. The main aim of the scheme is to explore as well as convert nano-enabled technologies towards clinical applications.

For the purpose of this report, Reports and Data have segmented global Nanomedicine Market on the basis of products, drug delivery system, application and region:

Product Outlook 

Therapeutics

Regenerative Medicine

In-vitro diagnostics

In-vivo diagnostic

Vaccines

Drug Delivery System Outlook 

Nanobots

Nanoghosts

Nanoclusters

Nanobubbles

Exosomes

Injectable Nanoparticle Generator

Dendrimers

Liposomes

Carbon nanotube

Graphene

Others

Application Outlook 

Oncology

Infectious diseases

Cardiology

Orthopedics

Others

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1048

Regional Outlook 

North America

U.S

Europe

Germany

UK

Asia Pacific

China

India

Latin America

Brazil

MEA

To know more about the report @ https://www.reportsanddata.com/report-detail/nanomedicine-market

Key Advantages of the Nanomedicine Market Report:

Detailed analysis of changing dynamics of the global Nanomedicine market

Valuable insights on key market growth driving trends and monetary competence over the forecast period

SWOT analysis and Porter’s Five Forces analysis for each key market player to offer competitive advantage to readers and investors

Comprehensive assessment of competitive landscape and regional analysis

Assessment of key factors driving and restraining market growth

Analysis of threats, limitations, growth prospects, opportunities, and barriers in the market

Strategic recommendations to key market players and new entrants to assist them in gaining a robust footing in the market

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1048

Thank you for reading our report. Customization of this report is available according to the requirement of the clients. For further query or information regarding this report, please get in touch with us and team will ensure your doubts are cleared.

Read More Related Reports:-

Nelarabine Market Size, Share & Analysis, By Product Type (Arranon, Atriance), By Application (Hospital, Pharmacy), By Region, Forecasts To 2027

Adagen Market Size, Share & Analysis, By Product Type (Pre-Filled, Vial), By Application (Hospital, Specialty Clinic, Diagnostic Center), By Region, Forecast To 2027

Sodium Stibogluconate Market Size, Share & Analysis, By Product Type (>98%, <98%), By Application (Injection, Others), By Region, Forecast To 2027